CorneaGen
  • SURGEON PORTAL
  • Contact Us
  • CORNEAL TISSUE
    • Tissue Overview
    • Tissue Services
      • DSAEK
      • DMEK
      • Pre-Loaded DMEK
      • Ampho B
      • PKP
      • ALK
      • BrightMEM
      • FLAK
      • Non-Sterile Sclera
    • Tissue Reimbursement
    • Adverse Reaction Reporting
    • Regulatory Information
    • Request Tissue
  • Sterile Tissue
    • CTAK
    • VisionGraft
      • Glaucoma
      • Cornea
    • Sclera
    • Reimbursement
      • CTAK Reimbursement
      • VisionGraft Reimbursement
    • Adverse Reaction Reporting
    • Regulatory Information
  • CTAK
    • CTAK Overview
    • CTAK International
    • CTAK Reimbursement
  • Products
    • Products Overview
    • EndoSerter-PL
    • EndoSerter
    • Cannula
    • DescePro System
    • Donor Punch
    • Recipient Trephine
  • Education
    • Online Training
    • Educational Videos
    • Wet Labs
    • Fellows Program
  • About Us
    • Our People
    • Our Partners
    • Our Locations
    • Reimbursement
    • Gift of Sight
    • Insights & Updates
    • Core Commitments
    • Innovation
    • Careers
Request Tissue & Products Contact Us
Growing for Greater Impact: CorneaGen Expands in Orlando to Better Serve Surgeons and Patients

Growing for Greater Impact: CorneaGen Expands in Orlando to Better Serve Surgeons and Patients

November 3, 2025

CorneaGen is excited to share that our expanded Orlando facility is now fully operational, marking a significant milestone in our continued growth and commitment to excellence. This new space represents more than a physical expansion; it’s a meaningful investment in our ability to support surgeons, honor donors and serve patients across Florida and beyond. 

 After 18 months of dedicated planning, construction and preparation, our Orlando operations have moved into a state-of-the-art facility nearly three times the size of our previous space, growing from 2,300 square feet to nearly 7,000. 

This expansion enables us to process and distribute significantly more tissue, supporting the growing needs of surgeons and their patients while strengthening donor operations throughout the region. Every aspect of this growth was designed to help CorneaGen better deliver on our mission to provide the highest quality donor tissue, unparalleled customer service and superior products to ophthalmologists. 

 

Designed for Excellence and Efficiency 

 The centerpiece of the new facility is a modular processing laboratory featuring four dedicated bays, which is a step up from the three areas in the former location. Combined with an optimized workflow layout, this advanced configuration enhances efficiency and consistency, allowing us to reliably deliver quality tissue to our surgeons. 

 Beyond functionality, we’ve created a space that reflects our commitment to excellence. With more natural light, modern design and an uplifting work environment, the facility embodies the same care and precision that define every cornea we process. 

 

 Strengthening Our Community and Partnerships 

Our new facility isn’t just a workspace, it’s a destination for connection. With dedicated areas to welcome donor partners, surgeons, hospitals and community stakeholders, we’re excited to create opportunities for collaboration and celebration. The moment you walk into the space, the real impact of our work to honor the gift of sight will be brought to life with large visual displays that highlight donor and recipient stories – allowing visitors to fully immerse into our mission. 

This milestone reflects the passion, collaboration and expertise of the CorneaGen team, all of whom bring an unwavering dedication to quality and excellence every day. From planning and design to technical execution and operational readiness, their collective effort made this achievement possible and ensured a seamless transition into our new space. While this achievement was made possible by the dedication of countless individuals, we’d like to recognize several key contributors, including Andre Clark, Lindsey Elbanhawy, Kevin Gibson, DiAnn McCormack, Andrew Beal, and Jessica Moore, along with the entire Orlando team, whose focus, collaboration, and determination brought this vision to life.  

 

Serving Surgeons Coast to Coast 

With the Orlando expansion joining our recently upgraded San Francisco, Seattle and Winston-Salem laboratories, CorneaGen now has a stronger foundation to serve surgeons from coast to coast, reinforcing our ongoing commitment to quality, innovation and partnership that define our mission. 

As we continue to grow, one thing remains constant: our unwavering commitment to the surgeons and patients we serve. Together, we’re creating a brighter future, one cornea at a time. 

Recent Articles

  • CEO Update – September 2025

    CEO Update – September 2025

    As we transition into fall after a fast-paced summer, CorneaGen’s...

    READ MORE
  • CTAK Expands Surgeon Access: Procedure Now Compatible with Ziemer GALILEI platform  

    CTAK Expands Surgeon Access: Procedure Now Compatible with Ziemer GALILEI...

    READ MORE
  • CEO Update – June 2025

    CEO Update – June 2025

    A message from Bernie Iliakis, President & CEO of CorneaGen...

    READ MORE
  • Bernie’s Quarterly Update – November 2024

    Bernie’s Quarterly Update – November 2024

    A message from Bernie Iliakis, President & CEO of CorneaGen...

    READ MORE
Navigation
  • Corneal Tissue
  • Sterile Tissue
  • CTAK
  • Products
  • Education
  • About Us
  • Request Tissue
Helpful Information
  • Reimbursement assistance
  • Adverse reaction reporting
  • Regulatory Information
  • KAMRA Support
  • Careers
Legal
  • Privacy Policy
  • Proprietary Terms and conditions
  • Regulatory Information
  • Vendor Information
  • Billing Terms and Conditions
  • Purchase Order Terms and Conditions
Connect
  • Contact Us
CorneaGen

©2025 CorneaGen

CorneaGen